Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis

*Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, Shandong Province, People’s Republic of China; and

†Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Cardiac Electrophysiology and Arrhythmia, Jinan, Shandong Province, People’s Republic of China.

Correspondence: Yi Han, PhD, 16766 Jingshi Road, Jinan, People’s Republic of China 250014 (e-mail: [email protected]).

This study was granted by the 2021 Shandong Medical Association Clinical Research Fund-Qilu Special Project YXH2022ZX02047, the Provincial Key Technology Research and Development Program of Shandong 2020RKB14165 and the Cultivation Fund of the First Affiliated Hospital of Shandong First Medical University QYPY2020NSFC0813.

The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jcvp.org).

Comments (0)

No login
gif